Grapes Pop these little globes of goodness for an instant liver boost
All statistical analyses were conducted using SPSS Statistics 19.0 software (IBM)
Disclosures: Wen Zhang: Nothing to Disclose, Wei Chen: Nothing to Disclose, Yameng Sun: Nothing to Disclose, Ning Zhang: Nothing to Disclose, Hong Li: Nothing to Disclose, Wenyue Wu: Nothing to Disclose, Xiaoning Wu: Nothing to Disclose, Xuzhen Yan: Nothing to Disclose, Qi Han: Nothing to Disclose, Aiting Yang: Nothing to Disclose, Hong You: Nothing to Disclose 2041 LYSYL OXIDASE INHIBITOR AMELIORATES ECM CROSS-LINKING AND INFILTRATING MACROPHAGES IN HEPATOCELLULAR CARCINOMA WITH FIBROSIS/ CIRRHOTIC BACKGROUND Basundhara Das 1 Sachin Sharma 2 Maryam Shaikh 3 Bornika Roy 1 Sampa Ghose 4 Subhrajit Biswas 1 , 1 Amity Centre for Liver Research (ACLR), Amity Institute of Molecular Medicine & Stem Cell Research, 2 Division of Gastroenterology and Hepatology, Department of Medicine, UCSF, USA, 3 Heersink school of Medicine, University of Alabama, Birmingham, USA, 4 Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India Background: During onset of hepatocellular carcinoma (HCC) in fibrosis/ cirrhotic microenvironment, secretion of extracellular matrix (ECM) proteins from hepatic stellate cells (HSCs) and cross-linking of ECM proteins by Lysyl Oxidase (LOX) are associated with endothelial cells (ECs) and infiltration of bone marrow derived macrophages
Healthcare professionals work closely with patients to combine this treatment with tailored lifestyle modifications, including diet and exercise, to maximize weight loss results
